Osama Hamdy
Senior Endocrinologist @Joslin Diabetes Center
Signup · Get unlimited contacts
WORK HISTORY
Senior Endocrinologist @Joslin Diabetes Center
EDUCATION
Mansoura University
MD, PhD, Endocrinology
Harvard University
Fellowship, Endocrinology, Diabetes and Metabolism Residency Program
Mansoura faculty of medicine
Bachelor of Medicine, Bachelor of Surgery (MBBS), Endocrinology
Mansoura University
Master in Science, Internal Medicine
SKILLS
ABOUT OSAMA HAMDY
Associate Professor of Medicine at Harvard Medical School and one of world’s thought leaders in diabetes, obesity, nutrition and digital health. Currently, senior endocrinologist, director of obesity clinical program and director of international medical affairs of Joslin Diabetes Center in Boston, MA. In Diabetes practice for 39 years post residency. Specialized in medical weight management in patients with diabetes and obesity. Studies clinical, metabolic and cardiovascular outcomes of short and long-term weight loss in diabetes. Nutrition and obesity expert and international thought leader, who shared in developing several national and international guidelines. Founder of the Weight Achievement and Intensive Treatment (Why WAIT) program at Joslin Clinic in 2005 and Diabetes Remission Outcome Program (DROP). Winner of the 2015 Michaela Modan Memorial Award of the American Diabetes Association for his research on long-term weight management in diabetes. Special interest in technology and digital health. Currently, the global 3rd most cited physician in diabetes technology according to Google Scholar. Author of the Harvard Publication best seller \"The Diabetes Breakthrough\", which is based on Why WAIT program. Co-chairs the global transcultural Diabetes Nutrition Algorithm (tDNA). Author of the obesity chapter of Medscape, WebMD, eMedicine and Cecil text book of Medicine. Co-Founder of Healthimation Inc, the first digital health studio in the US. Investigator in 2 NIH-funded landmark studies; National Diabetes Prevention Program (DPP) and Look AHEAD study. Leading innovator in medical nutrition therapy, obesity management and digital health. PI in several investigator-initiated clinical studies in nutrition, obesity, diabetes, and diabetes technology. PI of many clinical trials, especially those on GLP-1 Receptor Agonists. Innovations include Why WAIT, DROP and EVADE programs, which are widely implemented nationally and internationally. Has strong international connections and network of experts in the field of obesity, diabetes and nutrition. On the editorial and review boards of many medical journals in diabetes and obesity. Author of more than 150 original articles, reviews, book chapters, proceedings and medical publications. Has citations, h-index 43, i10-index 98.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.